21 results on '"Basir, Mir B."'
Search Results
2. Association of Preprocedural SYNTAX Score With Outcomes in Impella-Assisted High-Risk Percutaneous Coronary Intervention
- Author
-
Medranda, Giorgio A., Faraz, Haroon A., Thompson, Julia B., Zhang, Yiran, Bharadwaj, Aditya S., Osborn, Eric A., Abu-Much, Arsalan, Lansky, Alexandra J., Basir, Mir B., Moses, Jeffrey W., O’Neill, William W., Grines, Cindy L., and Baron, Suzanne J.
- Published
- 2024
- Full Text
- View/download PDF
3. Predicting Successful Chronic Total Occlusion Crossing With Primary Antegrade Wiring Using Machine Learning
- Author
-
Rempakos, Athanasios, Alexandrou, Michaella, Mutlu, Deniz, Kalyanasundaram, Arun, Ybarra, Luiz F., Bagur, Rodrigo, Choi, James W., Poommipanit, Paul, Khatri, Jaikirshan J., Young, Laura, Davies, Rhian, Benton, Stewart, Gorgulu, Sevket, Jaffer, Farouc A., Chandwaney, Raj, Jaber, Wissam, Rinfret, Stephane, Nicholson, William, Azzalini, Lorenzo, Kearney, Kathleen E., Alaswad, Khaldoon, Basir, Mir B., Krestyaninov, Oleg, Khelimskii, Dmitrii, Abi-Rafeh, Nidal, Elguindy, Ahmed, Goktekin, Omer, Aygul, Nazif, Rangan, Bavana V., Mastrodemos, Olga C., Al-Ogaili, Ahmed, Sandoval, Yader, Burke, M. Nicholas, and Brilakis, Emmanouil S.
- Published
- 2024
- Full Text
- View/download PDF
4. Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI
- Author
-
Abu-Much, Arsalan, Grines, Cindy L., Batchelor, Wayne B., Maini, Aneel S., Zhang, Yiran, Redfors, Björn, Bellumkonda, Lavanya, Bharadwaj, Aditya S., Moses, Jeffrey W., Truesdell, Alexander G., Li, Yanru, Baron, Suzanne J., Lansky, Alexandra J., Basir, Mir B., Cohen, David J., and O'Neill, William W.
- Published
- 2024
- Full Text
- View/download PDF
5. Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry
- Author
-
Rymer, Jennifer, Alhanti, Brooke, Kemp, Steven, Bhatt, Deepak L., Kochar, Ajar, Angiolillo, Dominick J., Diaz, Miguel, Garratt, Kirk N., Wimmer, Neil J., Waksman, Ron, Kirtane, Ajay J., Ang, Lawrence, Bach, Richard, Barker, Colin, Jenkins, Ronald, Basir, Mir B., Sullivan, Alex, El-Sabae, Hijrah, Brothers, Leo, Ohman, E. Magnus, Jones, W. Schuyler, Washam, Jeffrey B., and Wang, Tracy Y.
- Published
- 2024
- Full Text
- View/download PDF
6. Novel Risk Stratification and Hemodynamic Profiling in Acute Pulmonary Embolism
- Author
-
Arora, Sonali, primary, Vallabhajosyula, Saraschandra, additional, Aggarwal, Vikas, additional, Basir, Mir B., additional, Kelly, Bryan, additional, and Atreya, Auras R., additional
- Published
- 2024
- Full Text
- View/download PDF
7. Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella.
- Author
-
BASIR, MIR B., BENTLEY, DANA, TRUESDELL, ALEXANDER G., KUNKEL, KATHERINE, LEMOR, ALEJANDRO, MEGALY, MICHAEL, ALQARQAZ, MOHAMMAD, ALASWAD, KHALDOON, KHANDEWAL, AKSHAY, JORTBERG, ELISE, KALRA, SANJOG, KAKI, AMIR, BURKHOFF, DANIEL, MOSES, JEFFREY W., PINTO, DUANE S., STONE, GREGG W., and O'NEILL, WILLIAM W.
- Abstract
• Patients experiencing loss of pulse pressure (LOPP) during high-risk percutaneous coronary intervention (HR-PCI) are transiently dependent on mechanical circulatory support (MCS) devices. • LOPP during HR-PCI with Impella was common and occurred more frequently in patients with cardiomyopathy and low systolic blood pressure. LOPP was strongly associated with higher 90-day major adverse cardiac and cerebrovascular events, acute kidney injury, and mortality. • The ongoing randomized PROTECT-IV trial will determine whether Impella CP support during HR-PCI improves early and late clinical outcomes compared with the standard of care. The trial includes a right heart catheterization substudy that should help to define the role of invasive hemodynamics in stratifying and managing patients undergoing HR-PCI. Patients experiencing loss of pulse pressure (LOPP) during high-risk percutaneous coronary intervention (HR-PCI) are transiently dependent on mechanical circulatory support devices. We sought to define the frequency and clinic outcomes of patients who experience LOPP during HR-PCI. Patients enrolled in the PROTECT III study and had automated Impella controller logs capturing real-time hemodynamics were included in this analysis. A LOPP event was defined as a mean pulse pressure on Impella of <20 mm Hg for ≥5 seconds during PCI. Clinical characteristics and outcomes were then compared between those with and without LOPP. Logistic regression identified clinical and hemodynamic predictors of LOPP. We included 302 patients, of whom 148 patients (49%) experienced LOPP. Age, sex, and comorbidities were similar in patients with and without LOPP. Mean baseline systolic blood pressure (118.6 mm Hg vs 129.8 mm Hg; P <.001) and mean arterial pressure (86.9 mm Hg vs 91.6 mm Hg; P =.011) were lower in patients with LOPP, whereas heart rate (78 bpm vs 73 bpm; P =.012) was higher. Anatomical complexity was similar between groups. Patients with LOPP were more likely to experience major adverse cardiac and cerebrovascular events (23.5% vs 8.8%; P =.002), acute kidney injury (10.1% vs 2.6%; P =.030), and death (20.2% vs 7.9%; P =.008) within 90 days. A low baseline systolic blood pressure and cardiomyopathy were the strongest predictors of LOPP (P =.003 and P =.001, respectively). LOPP on Impella during HR-PCI was common and occurred more frequently in patients with cardiomyopathy and a low systolic blood pressure. LOPP was strongly associated with higher 90-day major adverse cardiac and cerebrovascular events, acute kidney injury, and mortality. Condensed Abstract We sought to define the frequency and clinic outcomes of patients who experience LOPP during high-risk percutaneous coronary intervention (HR-PCI). We included 302 patients, of whom 148 (49%) experienced LOPP. Patients with LOPP were more likely to experience major adverse cardiac and cerebrovascular events (23.5% vs 8.8%; P =.002), acute kidney injury (10.1% vs 2.6%; P =.030), and death (20.2% vs 7.9%; P =.008) within 90 days. A low baseline systolic blood pressure and cardiomyopathy were the strongest predictors of LOPP (P =.003 and P =.001, respectively). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Impact of Right Ventricular Dysfunction on Outcomes in Acute Myocardial Infarction and Cardiogenic Shock: Insights from the National Cardiogenic Shock Initiative.
- Author
-
GORGIS, SARAH, GUPTA, KARTIK, LEMOR, ALEJANDRO, BENTLEY, DANA, MOYER, CHRISTIAN, McRAE, THOMAS, KHUDDUS, MATHEEN, SHARMA, RAHUL, LIM, MICHAEL, NSAIR, ALI, WOHNS, DAVID, MEHRA, ADITYA, LIN, LANG, BHARADWAJ, ADITYA, TEDFORD, RYAN, KAPUR, NAVIN, COWGER, JENNIFER, O'NEILL, WILLIAM, and BASIR, MIR B.
- Abstract
Right ventricular dysfunction (RVD) complicates 30%–40% of cases in acute myocardial infarction (AMI) and cardiogenic shock (CS). There are sparse data on the effects of RVD on outcomes and the impact of providing early left ventricular (LV) mechanical circulatory support (MCS) on RV function and hemodynamics. Between July 2016 and December 2020, 80 sites participated in the study. All centers agreed to treat patients with AMI-CS using a standard protocol emphasizing invasive hemodynamic monitoring and rapid initiation of LV-MCS. RVD was defined as a right atrial (RA) pressure of >12 mm Hg and a pulmonary artery pulsatility index (PAPI) of <1 within 24 hours of the index procedure. The primary outcome was survival to discharge. In a subgroup analysis, data available from the Automated Impella Controller console was used to analyze diastolic suction alarms from LV placement signal and its relation to RVD. A total of 361 patients were included in the analysis, of whom 28% had RVD. The median age was 64 years (interquartile range 55–72 years), 22.7% were female and 75.7% were White. There was no difference in age, sex, or comorbidities between those with or without RVD. Patients with RVD had a higher probability of active CPR during LV-MCS implant (14.7% vs 6.3%), Society for Cardiovascular Angiography and Interventions stage E shock (39.2% vs 23.2%), and higher admission lactate levels (5.1 mg/dL vs 3.0 mg/dL). Survival to discharge was significantly lower among those with RVD (61.8% vs 73.4%, odds ratio 0.89, 95% confidence interval 0.36–0.95, P =.031). This association remained significant in the multivariate analysis. There was no significant difference in hemodynamic variables within 24 hours of LV-MCS support among those with or without RVD. At 24 hours, patients with a CPO of >0.6 W and a PAPi of >1 had a trend toward better survival to discharge compared with those with a CPO of ≤0.6 W and a PAPi of ≤1 (77.1% vs 54.6%, P =.092). Patients with RVD were significantly more likely to have diastolic suction alarms within 24 hours of LV-MCS initiation. RVD in AMI-CS is common and associated with worse survival to discharge. Early LV-MCS decreases filling pressures rapidly within the first 24 hours and decreases the rate of RVD. Achieving a CPO of >0.6 W and a PAPi of >1 within 24 hours is associated with high survival. Diastolic suction alarms may have usefulness as an early marker of RVD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Validation of the BCIS CHIP Score in chronic total occlusion percutaneous coronary intervention
- Author
-
Rempakos, Athanasios, primary, Alexandrou, Michaella, additional, Mutlu, Deniz, additional, Choi, James W., additional, Poommipanit, Paul, additional, Khatri, Jaikirshan J., additional, Young, Laura, additional, Jefferson, Brian, additional, Gorgulu, Sevket, additional, Jaffer, Farouc A., additional, Chandwaney, Raj, additional, Davies, Rhian, additional, Benton, Stewart, additional, Alaswad, Khaldoon, additional, Azzalini, Lorenzo, additional, Kearney, Kathleen E., additional, Krestyaninov, Oleg, additional, Khelimskii, Dmitrii, additional, Dattilo, Philip, additional, Reddy, Niranjan, additional, Abi‐Rafeh, Nidal, additional, Elguindy, Ahmed, additional, Goktekin, Omer, additional, Rangan, Bavana V., additional, Mastrodemos, Olga C., additional, Al‐Ogaili, Ahmed, additional, Sandoval, Yader, additional, Burke, Nicholas M., additional, Brilakis, Emmanouil S., additional, and Basir, Mir B., additional
- Published
- 2024
- Full Text
- View/download PDF
10. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
- Author
-
Bharadwaj, Aditya S., Abu-Much, Arsalan, Maini, Aneel S., Zhou, Zhipeng, Yanru Li, Batchelor, Wayne B., Grines, Cindy L., Baron, Suzanne J., Redfors, Björn, Lansky, Alexandra J., Basir, Mir B., and O'Neill, William W.
- Abstract
BACKGROUND: Prior studies have found that patients with chronic kidney disease (CKD) have worse outcomes following percutaneous coronary intervention (PCI). There are no data about patients with advanced CKD undergoing Impellasupported high-risk PCI. We, therefore, aimed to evaluate angiographic characteristics and clinical outcomes in patients with CKD who received Impella-supported high-risk PCI as part of the catheter-based ventricular assist device PROTECT III study (A Prospective, Multi-Center, Randomized Controlled Trial of the IMPELLA RECOVER LP 2.5 System Versus Intra Aortic Balloon Pump [IABP] in Patients Undergoing Non Emergent High Risk PCI). METHODS: Patients enrolled in the PROTECT III study were analyzed according to their baseline estimated glomerular filtration rate (eGFR). The primary outcome was 90-day major adverse cardiovascular and cerebrovascular events (the composite of all-cause death, myocardial infarction, stroke/transient ischemic attack, and repeat revascularization). RESULTS: Of 1237 enrolled patients, 1052 patients with complete eGFR baseline assessment were evaluated: 586 with eGFR =60 mL/min per 1.73 m2, 190 with eGFR =45 to <60, 105 with eGFR =30 to <45, and 171 with eGFR <30 or on dialysis. Patients with lower eGFR (all groups with eGFR <60) were more frequently females and had a higher prevalence of hypertension, diabetes, anemia, and peripheral artery disease. The baseline Synergy Between PCI With Taxus and Cardiac Surgery score was similar between groups (28.2±12.6 for all groups). Patients with lower eGFR were more likely to have severe coronary calcifications and higher usage of atherectomy. There were no differences in individual PCI-related coronary complications between groups, but the rates of overall PCI complications were less frequent among patients with lower eGFR. Major adverse cardiovascular and cerebrovascular events at 90 days and 1-year mortality were significantly higher among patients with eGFR <30 mL/min per 1.73 m2 or on dialysis. CONCLUSIONS: Patients with advanced CKD undergoing Impella-assisted high-risk PCI tend to have higher baseline comorbidities, severe coronary calcification, and higher atherectomy usage, yet CKD was not associated with a higher rate of immediate PCI-related complications. However, 90-day major adverse cardiovascular and cerebrovascular events and 1-year mortality were significantly higher among patients with eGFR<30 mL/min per 1.73 m2 or on dialysis. Future studies of strategies to improve intermediate and long-term outcomes of these high-risk patients are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals.
- Author
-
Al‐Ogaili, Ahmed, Alexandrou, Michaella, Rempakos, Athanasios, Mutlu, Deniz, Choi, James W., Poommipanit, Paul, Khatri, Jaikirshan J., Alaswad, Khaldoon, Basir, Mir B., Chandwaney, Raj H., Gorgulu, Sevket, ElGuindy, Ahmed M., Elbarouni, Basem, Jaber, Wissam, Rinfret, Stephane, Nicholson, William, Jaffer, Farouc A., Aygul, Nazif, Azzalini, Lorenzo, and Kearney, Kathleen E.
- Published
- 2024
- Full Text
- View/download PDF
12. Use of percutaneous mechanical circulatory support for right ventricular failure.
- Author
-
Gupta, Kartik, Lemor, Alejandro, Alkhatib, Ahmad, McBride, Patrick, Cowger, Jennifer, Grafton, Gillian, Alaswad, Khaldoon, O'Neill, William, Villablanca, Pedro, and Basir, Mir B.
- Published
- 2024
- Full Text
- View/download PDF
13. Early vs. delayed mechanical circulatory support in patients with acute myocardial infarction and cardiogenic shock.
- Author
-
Buda, Kevin G, Hryniewicz, Katarzyna, Eckman, Peter M, Basir, Mir B, Cowger, Jennifer A, Alaswad, Khaldoon, Mukundan, Srini, Sandoval, Yader, Elliott, Andrea, Brilakis, Emmanouil S, and Megaly, Michael S
- Published
- 2024
- Full Text
- View/download PDF
14. Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock Stage
- Author
-
Hanson, Ivan D., primary, Rusia, Akash, additional, Palomo, Andres, additional, Tawney, Adam, additional, Pow, Timothy, additional, Dixon, Simon R., additional, Meraj, Perwaiz, additional, Sievers, Eric, additional, Johnson, Michael, additional, Wohns, David, additional, Ali, Omar, additional, Kapur, Navin K., additional, Grines, Cindy, additional, Burkhoff, Daniel, additional, Anderson, Mark, additional, Lansky, Alexandra, additional, Naidu, Srihari S., additional, Basir, Mir B., additional, and O'Neill, William, additional
- Published
- 2024
- Full Text
- View/download PDF
15. Cardiogenic shock in a young woman with SCAD: The importance of early access to VA-ECMO in the community
- Author
-
Ya'Qoub, Lina, Alqarqaz, Mohammad, Cowger, Jennifer, Nemeh, Hasan, Basir, Mir B., Alaswad, Khaldoon, and Koenig, Gerald
- Published
- 2024
- Full Text
- View/download PDF
16. Chronic total occlusion percutaneous coronary intervention of anomalous coronary arteries: insights from the PROGRESS CTO registry.
- Author
-
Hirata GM, Rempakos A, Walker Boyd A, Alexandrou M, Mutlu D, Choi JW, Poommipanit P, Khatri JJ, Young L, Davies R, Gorgulu S, Jaffer FA, Chandwaney R, Jefferson B, Elbarouni B, Azzalini L, Kearney KE, Alaswad K, Basir MB, Krestyaninov O, Khelimskii D, Aygul N, Abi-Rafeh N, ElGuindy A, Goktekin O, Rangan BV, Mastrodemos OC, Al-Ogaili A, Sandoval Y, Burke MN, Brilakis ES, and Frizzell JD
- Abstract
Background: There is limited information about the frequency and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in anomalous coronary arteries (ACA)., Methods: We examined the clinical and angiographic characteristics and procedural outcomes of CTO PCI in ACA among 14,173 patients who underwent 14,470 CTO PCIs at 46 US and non-US centers between 2012 and 2023., Results: Of 14,470 CTO PCIs, 36 (0.24%) were CTO PCIs in an ACA. ACA patients had similar baseline characteristics as those without an ACA. The type of ACA in which the CTO lesion was found were as follows: anomalous origin of the right coronary artery (ARCA) (17, 48.5%), anomalous origin of left circumflex coronary artery (9, 25.7%), left anterior descending artery and left circumflex artery with separate origins (4, 11.4%), anomalous origin of the left anterior descending artery (2, 5.7%), dual left anterior descending artery (2, 5.7%) and woven coronary artery 1 (2.8%). The Japan CTO score was similar between both groups (2.17 ± 1.32 vs 2.38 ± 1.26, p = 0.30). The target CTO in ACA patients was more likely to have moderate/severe tortuosity (44% vs 28%, p = 0.035), required more often use of retrograde approach (27% vs 12%, p = 0.028), and was associated with longer procedure (142.5 min vs 112.00 min [74.0, 164.0], p = 0.028) and fluoroscopy (56 min [40, 79 ml] vs 42 min [25, 67], p = 0.014) time and higher contrast volume (260 ml [190, 450] vs 200 ml [150, 300], p = 0.004) but had similar procedural (91.4% vs 85.6%, p = 0.46) and technical (91.4% vs 87.0%, p = 0.59) success. No major adverse cardiac events (MACE) were seen in ACA patients (0% [0] vs 1.9% [281] in non-ACA patients, p = 1.00). Two coronary perforations were reported in ACA CTO PCI (p = 0.7 vs. non-ACA CTO PCI)., Conclusions: CTO PCI of ACA comprise 0.24% of all CTO PCIs performed in the PROGRESS CTO registry and was associated with higher procedural complexity but similar technical and procedural success rates and similar MACE compared with non-ACA CTO PCI., (© 2024 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
17. The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO Registry.
- Author
-
Rymer J, Pichan C, Page C, Alhanti B, Bhatt DL, Kochar A, Angiolillo DJ, Diaz M, Wimmer NJ, Waksman R, Ang L, Bach R, Jenkins R, El-Sabae H, Brothers L, Ohman EM, Jones WS, Washam JB, Wang TY, Narcisse D, and Basir MB
- Subjects
- Humans, Female, Male, Aged, Middle Aged, Purinergic P2Y Receptor Antagonists administration & dosage, Purinergic P2Y Receptor Antagonists therapeutic use, Treatment Outcome, Platelet Aggregation Inhibitors administration & dosage, Platelet Aggregation Inhibitors therapeutic use, Myocardial Infarction drug therapy, Shock, Cardiogenic drug therapy, Adenosine Monophosphate analogs & derivatives, Adenosine Monophosphate therapeutic use, Adenosine Monophosphate administration & dosage, Registries
- Abstract
Introduction: Little is known about the use of cangrelor in patients with myocardial infarction (MI) presenting with cardiogenic shock (CS)., Methods: CAMEO (Cangrelor in Acute MI: Effectiveness and Outcomes) is a multicenter observational registry evaluating platelet inhibition in patients with MI. We examined the duration of cangrelor infusion and the amount of time to transition from cangrelor to an oral P2Y
12 inhibitor in patients with CS. We also assessed major adverse cardiovascular events (MACEs) and bleeding risks, stratified by dosage duration, time to transition and oral P2Y12 inhibitor potency., Results: Among 2352 cangrelor-treated patients with MI, 249 patients were in CS. Among the patients with CS, 16 (6.4%) received the "bridge" infusion dose, 202 (81.1%) the PCI cangrelor infusion dose, and 30 (12.0%) had a combination of both infusion doses. Patients with CS had a median age of 66 years; 32% were women; 21% were Black patients; 35% had diabetes; 19% received thrombectomy; and 59% received mechanical circulatory support (MCS) (35% intra-aortic balloon pump, 27% Impella). The median duration of infusion was 3.9 (2-21.5 hours) in patients with CS and was 2 (1.6-3.1 hours) for all cangrelor-treated patients. The median duration of transition from cangrelor to oral P2Y12 inhibitor administration was 0.1 (-0.5-21.0 hours) for patients with CS. In multivariable modeling, chronic lung disease and the use of MCS and was associated with longer cangrelor infusions (defined as > 3.9 hours). Among cangrelor-treated patients with CS, 24.1% of these patients had a bleeding event, and 41.8% had a MACE event. After adjustment, a longer cangrelor infusion duration was associated with increased risk of bleeding (P < 0.05)., Conclusions: The median duration of cangrelor infusion was longer for patients presenting with CS. Use of MCS was associated with longer cangrelor infusion durations in patients with CS. Further work is needed to understand the pharmacodynamics of antiplatelet agents in patients with CS., (Copyright © 2024. Published by Elsevier Inc.)- Published
- 2024
- Full Text
- View/download PDF
18. Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
- Author
-
Abu-Much A, Grines CL, Chen S, Batchelor WB, Zhao D, Falah B, Maini AS, Redfors B, Bellumkonda L, Bharadwaj AS, Moses JW, Truesdell AG, Zhang Y, Zhou Z, Baron SJ, Lansky AJ, Basir MB, O'Neill WW, and Cohen DJ
- Abstract
Background: Mitral valve regurgitation (MR) is associated with worse outcomes in patients undergoing percutaneous coronary intervention (PCI). We sought to evaluate outcomes of Impella-supported high-risk PCI (HRPCI) patients according to MR severity., Methods: Patients from the PROTECT III study undergoing Impella-supported HRPCI were stratified into 4 groups according to MR severity: No or trace MR, mild MR, moderate MR, and severe MR. Immediate PCI-related complications, major adverse cardiovascular and cerebrovascular events (MACCE: all-cause death, myocardial infarction, stroke/transient ischemic attack, and repeat revascularization) at 90 days and death at 1-year were assessed., Results: From March 2017 to March 2020, 631 patients who underwent Impella-supported HRPCI in the PROTECT III study had evaluable MR severity at baseline. Patients with severe MR had lower body mass indices, lower left ventricular ejection fractions (LVEFs), and were more frequently diagnosed with heart failure. The incidence of immediate PCI-related complications was similar between groups. Unadjusted 90-day MACCE and 1-year mortality rates were numerically higher in patients with severe MR compared to the other study groups yet without reaching statistical significance. In multivariable analyses, there was no significant association between the presence of severe MR for 90-day MACCE or 1-year mortality compared with other degrees of MR (adj. HR = 1.71, 95% CI [0.73, 3.98], p = 0.21; adj. HR = 1.79, 95% CI [0.86, 3.74], p = 0.12, respectively)., Conclusions: Impella-supported HRPCI patients with moderate or severe MR exhibited a higher prevalence of heart failure, lower LVEF, and longer hospital stays. Patients with severe MR showed numerically higher unadjusted rates of 90-day MACCE and 1-year mortality compared to other groups, however these differences did not reach statistical significance even after adjustment for potential confounders., Clinical Trial Information: Trial Name: The Global cVAD Study (cVAD) ClinicalTrial.govIdentifier:NCT04136392 URL: https://clinicaltrials.gov/ct2/show/NCT04136392?term=cvad&draw=2&rank=2., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
19. Predictors of successful primary antegrade wiring in chronic total occlusion percutaneous coronary intervention.
- Author
-
Rempakos A, Alexandrou M, Mutlu D, Choi JW, Poommipanit P, Khatri JJ, Young L, Dattilo P, Sadek Y, Davies R, Gorgulu S, Jaffer FA, Chandwaney R, Jefferson B, Elbarouni B, Azzalini L, Kearney KE, Alaswad K, Basir MB, Krestyaninov O, Khelimskii D, Aygul N, Abi-Rafeh N, Elguindy A, Goktekin O, Rangan BV, Mastrodemos OC, Al-Ogaili A, Sandoval Y, Burke MN, Brilakis ES, and Kalyanasundaram A
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Chronic Disease, Treatment Outcome, Prospective Studies, Follow-Up Studies, Coronary Occlusion surgery, Coronary Occlusion diagnosis, Percutaneous Coronary Intervention methods, Coronary Angiography methods, Registries, Coronary Vessels diagnostic imaging, Coronary Vessels surgery
- Abstract
Background: Antegrade wiring is the most commonly used chronic total occlusion (CTO) crossing technique., Methods: Using data from the PROGRESS CTO registry (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention; Clinicaltrials.gov identifier: NCT02061436), we examined the clinical and angiographic characteristics and procedural outcomes of CTO percutaneous coronary interventions (PCIs) performed using a primary antegrade wiring strategy., Results: Of the 13 563 CTO PCIs performed at 46 centers between 2012 and 2023, a primary antegrade wiring strategy was used in 11 332 (83.6%). Upon multivariable logistic regression analysis, proximal cap ambiguity (odds ratio [OR]: 0.52; 95% CI, 0.46-0.59), side branch at the proximal cap (OR: 0.85; 95% CI, 0.77-0.95), blunt/no stump (OR: 0.52; 95% CI: 0.47-0.59), increasing lesion length (OR [per 10 mm increase]: 0.79; 95% CI, 0.76-0.81), moderate to severe calcification (OR: 0.73; 95% CI, 0.66-0.81), moderate to severe proximal tortuosity (OR: 0.67; 95% CI, 0.59-0.75), bifurcation at the distal cap (OR: 0.66; 95% CI, 0.59-0.73), left anterior descending artery CTO (OR [vs right coronary artery]: 1.44; 95% CI, 1.28-1.62) and left circumflex CTO (OR [vs right coronary artery]: 1.22; 95% CI, 1.07-1.40), non-in-stent restenosis lesion (OR: 0.56; 95% CI, 0.49-0.65), and good distal landing zone (OR: 1.18; 95% CI, 1.06-1.32) were independently associated with primary antegrade wiring crossing success., Conclusions: The use of antegrade wiring as the initial strategy was high (83.6%) in our registry. We identified several parameters associated with primary antegrade wiring success.
- Published
- 2024
- Full Text
- View/download PDF
20. STEMI in a patient with recent intracranial hemorrhage.
- Author
-
Maki M, El-Khatib L, and Basir MB
- Subjects
- Male, Humans, Middle Aged, Intracranial Hemorrhages complications, Intracranial Hemorrhages diagnosis, Vomiting, Emergency Service, Hospital, Tomography, X-Ray Computed, ST Elevation Myocardial Infarction complications, ST Elevation Myocardial Infarction diagnosis
- Abstract
A 63-year-old male patient with a history of hypertension presented to the emergency department with a one-day history of dizziness, nausea, and vomiting.
- Published
- 2024
- Full Text
- View/download PDF
21. Use of plaque modification microcatheters during percutaneous coronary interventions for chronic total occlusion: insights from the PROGRESS-CTO Registry.
- Author
-
Mutlu D, Rempakos A, Alexandrou M, Al-Ogaili A, Jaffer FA, Alaswad K, Khatri JJ, Young L, Basir MB, Krestyaninov O, Khelimskii D, Gorguluu S, Goktekin O, Choi JW, Chandwaney RH, Potluri S, Poommipanit P, Uretsky B, Kandzari DE, Aygul N, Azzalini L, Rangan BV, Mastrodemos OC, Sandoval Y, Burke MN, and Brilakis ES
- Abstract
Plaque modification microcatheters (PM) (Tornus [Asahi] and Turnpike Gold [Teleflex]) are devices that are mainly used to modify the cap or lesion and maintain good support in chronic total occlusion (CTO) percutaneous coronary artery intervention (PCI). We evaluated the frequency of use and outcomes of plaque modification microcatheters in an international multicenter registry. Plaque modification microcatheters were utilized in 242 cases (1.6%: Tornus in 51% and Turnpike Gold in 49%) with decreasing frequency over time (P-for-trend: 0.007 and 0.035, respectively). Technical and procedural success and the incidence of major cardiac adverse events were similar with Tornus and Turnpike Gold use. PM are infrequently utilized in CTO-PCI and are associated with high success and acceptable complication rates.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.